• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS2302457 吸入用布地奈德混悬液 budesonide Inhalation Chemical Drugs(4) Generic Drug 2023-09-12 Zhejiang Gaozhi Pharmaceutical Technology Co Ltd;Zhejiang Cdmo Pharmaceutical Co Ltd view
CYHB2300191 吸入用布地奈德混悬液 budesonide Inhalation Chemical Drugs(4) Supplementary Application 2023-02-01 Sichuan Purity Pharmaceutical Co Ltd view
JYHZ2500095 布地奈德福莫特罗吸入粉雾剂(II) budesonide;formoterol fumarate Inhalation Chemical Drugs License Renew 2025-04-23 AstraZeneca AB;Astrazeneca Investment (China) Co Ltd view
JYHL2100003 布地奈德福莫特罗吸入粉雾剂 budesonide;formoterol fumarate Inhalation Chemical Drugs(5.2) Import Drug Application 2021-02-11 Orion Corporation In Review 2021-02-11 view
JXHL2400148 布地奈德硫酸沙丁胺醇吸入气雾剂 budesonide;salbutamol sulfate Inhalation Chemical Drugs(2.2) Import Drug Application 2024-06-25 Astrazeneca Pharmaceuticals Lp;AstraZeneca Global R&D (China) Co Ltd view
CYHS2303217 吸入用布地奈德混悬液 budesonide Inhalation Chemical Drugs(4) Generic Drug 2023-11-22 Jiangsu Xipula Pharmaceutical Co Ltd view
CYHS2301196 吸入用布地奈德混悬液 budesonide Inhalation Chemical Drugs(4) Generic Drug 2023-04-29 Nanjing Licheng Pharmaceutical Co Ltd view
JYHB2101209 吸入用布地奈德混悬液 budesonide Inhalation Chemical Drugs Supplementary Application 2021-06-25 Astrazeneca Pty Ltd view
CYHB2401442 吸入用布地奈德混悬液 budesonide Inhalation Chemical Drugs(4) Supplementary Application 2024-09-12 Nanjing Licheng Pharmaceutical Co Ltd view
JYHB2001584 布地奈德吸入粉雾剂 budesonide Powder for inhalation Chemical Drugs Supplementary Application 2020-08-26 Orion Corporation;Orion Corporation Orion Pharma Espoo Plant Filed 2020-09-09 view
JYHZ2400009 布地奈德鼻喷雾剂 budesonide Spray Chemical Drugs License Renew 2024-01-17 Chongqing Hemony Pharmaceutical Co Ltd;Synmosa Biopharma Corporation;Taiwan Hemony Pharmaceutical Co Ltd view
JYHZ2300280 吸入用布地奈德混悬液 budesonide Inhalation Chemical Drugs License Renew 2023-06-29 Astrazeneca Investment (China) Co Ltd;Astrazeneca Pty Ltd view
JYHB2200408 吸入用布地奈德混悬液 budesonide Inhalation Chemical Drugs Supplementary Application 2022-07-28 Astrazeneca Pty Ltd view
JYHB2200542 布地奈德吸入粉雾剂 budesonide Powder for inhalation Chemical Drugs Supplementary Application 2022-10-09 Orion Corporation;Orion Corporation Orion Pharma Espoo Plant view
JYHB2500064 布地奈德肠溶胶囊 budesonide Capsule Chemical Drugs(5.1) Supplementary Application 2025-02-15 Everest Medicines(Singapore)Pte Ltd;Patheon Pharmaceuticals Inc view
CYHS2401432 吸入用布地奈德混悬液 budesonide Inhalation Chemical Drugs(4) Generic Drug 2024-05-12 Zhejiang Cdmo Pharmaceutical Co Ltd view
CYHS2302707 吸入用布地奈德混悬液 budesonide Inhalation Chemical Drugs(4) Generic Drug 2023-10-12 Zhejiang Cdmo Pharmaceutical Co Ltd;Ningbo Meishu Medical Technology Co Ltd view
CYHS2300732 吸入用布地奈德混悬液 budesonide Inhalation Chemical Drugs(4) Generic Drug 2023-03-08 Hebei Renhe Yikang Pharmaceutical Co Ltd;Renhe Yikang Group Co Ltd view
CYHB2101358 布地奈德吸入气雾剂 budesonide Aerosol Chemical Drugs Supplementary Application 2021-06-04 Lunan BETTER Pharmaceutical Co Ltd view
CYHS2402268 吸入用布地奈德混悬液 budesonide Inhalation Chemical Drugs(4) Generic Drug 2024-07-19 Lexenpharm (Suzhou) Limited view